Skip to main navigation
  • Skip to content
  • Skip to primary sidebar
Back to the Corporate Site
Veloxis

Back to the Corporate Site

Investor Relations

IR Menu

  • News & Releases
  • Download Center
  • Corporate Governance
    • Governance Documents
    • Risk Management
    • Reporting Compliance
    • Violations and Concerns
    • Whistleblower Policy
    • Whistleblowing Guidelines
  • Financial Information
    • Outlook
  • General Meetings

Governance Documents

Governance Documents

Governance Statements
Statutory Corporate Governance Report for 2018, cf. art. 107b of the Danish Financial Statements Act 1.4 MB
Statutory Corporate Governance Report for 2017, cf. art. 107b of the Danish Financial Statements Act 718.5 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2016) 681.6 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2015) 496.8 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2014) 500.2 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2013) 401.4 KB
Veloxis Corporate Governance 2011 - English 518.5 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2012) 671.1 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2011) 694.7 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2012) 500.9 KB
US Compliance Statements
Code of Business Conduct 866.5 KB
US Compliance Statements

To request a summary of the Veloxis Comprehensive Compliance Program, please call +1 919 591 3090.
101.4 KB
Documents
Articles of Association 146.3 KB
Remuneration Committee Charter 82.8 KB
Audit Committee Charter 398.2 KB
Efforts by Veloxis to Obtain Final Approval for Envarsus® XR from the Food and …
IR Policy 173.6 KB
Remuneration Policy 100.1 KB
Rules of Procedure for the Board of Directors 198.9 KB

Submenu - Corporate Governance

  • Corporate Governance
  • Governance Documents
  • Risk Management
  • Reporting Compliance
  • Violations and Concerns
  • Whistleblower Policy
  • Guidelines for Reported Employees

Latest News & Releases

Jun 22, 2020
Transplant Therapeutics Consortium Receives Acceptance of Letter-of-Intent for iBox Scoring System as a Reasonably Likely Surrogate Endpoint from the Biomarker Qualification Program
Feb 17, 2020
Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020

View All

© 2022 All rights reserved. Veloxis Pharmaceuticals Inc. ENV-18-090.0 06/18

info@veloxis.com | 1-844-VELOXIS (835-6947), Monday-Friday, 9AM-7PM ET

Sitemap | Contact | Privacy Policy | Disclaimer